How many insider trades does FilingIQ track for ICCC?

FilingIQ tracks 176 Form 4 insider transactions for ICCC (IMMUCELL CORP /DE/), covering filings from Aug 27, 2015 onwards. 7 of those were filed in the last 90 days.

Are ICCC insiders net buyers or net sellers?

Across the full Form 4 history for ICCC, 44 transactions (25%) were open-market purchases and 29 (16%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ICCC insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is ICCC in?

IMMUCELL CORP /DE/ (ICCC) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $60.34M.

ICCC insider trading

NasdaqCM Healthcare

IMMUCELL CORP /DE/ — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

176

Last 90 days

Buys / sells

25% / 16%

Market cap

$60.34M

About IMMUCELL CORP /DE/

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments: Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, the company developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.

Company website: immucell.com

ICCC insider activity at a glance

FilingIQ has scored 176 insider transactions for ICCC since Aug 27, 2015. The most recent filing in our index is dated Apr 15, 2026.

Across the full history, 44 open-market purchases and 29 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ICCC insider trades is 42.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live ICCC trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for ICCC?: FilingIQ tracks 176 Form 4 insider transactions for ICCC (IMMUCELL CORP /DE/), covering filings from Aug 27, 2015 onwards. 7 of those were filed in the last 90 days.
Are ICCC insiders net buyers or net sellers?: Across the full Form 4 history for ICCC, 44 transactions (25%) were open-market purchases and 29 (16%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ICCC insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ICCC in?: IMMUCELL CORP /DE/ (ICCC) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $60.34M.

Methodology & sources

Every ICCC insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.